Published in
Wiley, Clinical Pharmacology in Drug Development, 5(11), p. 654-665, 2022
DOI: 10.1002/cpdd.1058
Links
Tools
Safety, Pharmacokinetics, and Pharmacodynamics of Etavopivat (FT‐4202), an Allosteric Activator of Pyruvate Kinase‐R, in Healthy Adults: A Randomized, Placebo‐Controlled, Double‐Blind, First‐in‐Human Phase 1 Trial
Journal article published in 2022 by
Sanjeev Forsyth,
Patricia Schroeder,
James Geib,
Leela Vrishabhendra,
Diamantis G. Konstantinidis,
Kari LaSalvia,
Maria D. Ribadeneira,
Eric Wu,
Patrick Kelly,
Theodosia A. Kalfa 
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 